TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34265434

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 554

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 554
Study: 34325885

Group type: EXPERIMENTAL
Intervention: Eplerenone (100 mg-200 mg)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 35463059

Group type: EXPERIMENTAL
Intervention: Nigella sativa oil (2 g/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 46
Study: 33288923

Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (live-attenuated followed by AS03-adjuvanted inactivated vaccine)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (live-attenuated followed by inactivated vaccine)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Chimeric hemagglutinin-based vaccines (twice AS03-adjuvanted inactivated vaccine)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (intranasal followed by intramuscular)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (twice intramuscular)
Number of subjects: 66
Study: 35107519

Group type: EXPERIMENTAL
Intervention: Açaí Group (100mg of açaí extract)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo Group (without active)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups (Açaí and Placebo)
Number of subjects: 30
Study: 32283820

Group type: EXPERIMENTAL
Intervention: Imaging Training (IMG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study: 35049127

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (cognitive training, physical activity, nutrition, omega-3 fatty acids)
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Higher dose of intervention
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Optimal dose of intervention
Number of subjects: 749
Study: 32392231

Group type: EXPERIMENTAL
Intervention: Exercise-based cardiac rehabilitation (43% participation rate)
Number of subjects: 19136

Group type: COMPARATOR
Intervention: Non-attenders of exercise-based cardiac rehabilitation
Number of subjects: 19136
Study: 36156704

Group type: EXPERIMENTAL
Intervention: Conscious Sedation (CS)
Number of subjects: 87

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 87
Study: 32901094

Group type: EXPERIMENTAL
Intervention: Baseline anxiety levels measured using the MAX‐PC questionnaire.
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Percentage of positive biopsy cores.
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Baseline anxiety levels.
Number of subjects: 302
Study: 32727509

Group type: EXPERIMENTAL
Intervention: Extended training condition (prolonged exposure workshop followed by 6-8 months of post-workshop expert case consultation)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Extended training condition
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard training condition
Number of subjects: 103
Study: 35588357

Group type: EXPERIMENTAL
Intervention: Usual care plus breathing exercises (UC+BrEX)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 193
Study: 32723512

Group type: EXPERIMENTAL
Intervention: Electronic hand-held pulsed vibration device
Number of subjects: 166

Group type: COMPARATOR
Intervention: Topical anaesthesia
Number of subjects: 166
Study: 36250307

Group type: EXPERIMENTAL
Intervention: ACURATE neo2
Number of subjects: 1356

Group type: COMPARATOR
Intervention: SAPIEN 3 Ultra
Number of subjects: 1356
Study: 33507363

Group type: EXPERIMENTAL
Intervention: rIPC + Exercise
Number of subjects: 19

Group type: COMPARATOR
Intervention: rIPC only
Number of subjects: 19
Study: 36219590

Group type: EXPERIMENTAL
Intervention: Antipyretics + warm compresses
Number of subjects: 33

Group type: COMPARATOR
Intervention: Antipyretics
Number of subjects: 33
Study: 33145944

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 32629403

Group type: EXPERIMENTAL
Intervention: Monomethyl fumarate (MMF) 190 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dimethyl fumarate (DMF) 240 mg
Number of subjects: 100
Study: 34046894

Group type: EXPERIMENTAL
Intervention: Minimally invasive ultrasound-guided carpal tunnel release (USCTR)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Open carpal tunnel release (OCTR)
Number of subjects: 89
Study: 33180376

Group type: EXPERIMENTAL
Intervention: ICS/LABA/LAMA (HFA-BDP + olodaterol 5 µg/tiotropium 5 µg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: ICS/LABA (HFA-BDP + olodaterol 5 µg)
Number of subjects: 16
Study: 36333954

Group type: EXPERIMENTAL
Intervention: Zoledronic Acid (5 mg intravenously)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Denosumab and Teriparatide (20-μg or 40-μg daily)
Number of subjects: 76
Study: 33476973

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Fluoxetine + Alprazolam
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study: 32725695

Group type: EXPERIMENTAL
Intervention: Blood Flow Restriction (BFR) treatment
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (no BFR treatment)
Number of subjects: 10
Study: 36123593

Group type: EXPERIMENTAL
Intervention: Tight glucose control (80–110 mg/dl) using LOGIC-Insulin software
Number of subjects: 9230

Group type: COMPARATOR
Intervention: Liberal glucose control (targeting 180–215 mg/dl, initiating insulin only when hyperglycemia >215 mg/dl)
Number of subjects: 9230
Study: 34198888

Group type: EXPERIMENTAL
Intervention: Palm Stearin (PS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Butter
Number of subjects: 24
Study: 35559993

Group type: EXPERIMENTAL
Intervention: 1 μM cFEE
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: 100 μM cFEE
Number of subjects: 1629

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1629

Group type: EXPERIMENTAL
Intervention: cFEE (1 μM and 100 μM)
Number of subjects: 1629
Study: 33297893

Group type: EXPERIMENTAL
Intervention: Intravenous argatroban (100 µg/kg bolus followed by 3 µg/kg/min for 12 h)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Intravenous eptifibatide (135 µg/kg bolus followed by 0.75 µg/kg/min infusion for 2 h)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 1200
Study: 34304609

Group type: EXPERIMENTAL
Intervention: Cumulative new or newly enlarging T2 lesions at 96 weeks
Number of subjects: 889

Group type: EXPERIMENTAL
Intervention: Normalized brain volume loss at 48 weeks
Number of subjects: 889

Group type: COMPARATOR
Intervention: MRI measures
Number of subjects: 889
Study: 32149759

Group type: COMPARATOR
Intervention: Carbetocin 50 µg (C50)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Carbetocin 100 µg (C100)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no carbetocin)
Number of subjects: 50
Study: 33807703

Group type: EXPERIMENTAL
Intervention: Rice meal group (RMG)
Number of subjects: 105
Study: 33049909

Group type: EXPERIMENTAL
Intervention: Family-Based REDUCE Intervention Program
Number of subjects: 122

Group type: COMPARATOR
Intervention: Wait-list group (Control)
Number of subjects: 122
Study: 35837833

Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg)
Number of subjects: 10
Study: 36086927

Group type: EXPERIMENTAL
Intervention: Subcision plus Stromal-Vascular Fraction (SVF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Subcision alone
Number of subjects: 10
Study: 33203385

Group type: EXPERIMENTAL
Intervention: CAMP (summer day camp)
Number of subjects: 94

Group type: COMPARATOR
Intervention: SAU (unstructured summer as usual)
Number of subjects: 94
Study: 33402403

Group type: COMPARATOR
Intervention: Coenzyme Q10 (CoQ10) supplementation
Number of subjects: 371
Study: 32460511

Group type: EXPERIMENTAL
Intervention: Ultra-low-dose (ULD) protocol (axial scan)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional helical mode (Group B)
Number of subjects: 97
Study: 32618255

Group type: EXPERIMENTAL
Intervention: Mass drug administration and standard of care package (including improved surveillance, increased access to malaria case management, and sustained high levels of vector control coverage)
Number of subjects: 1620

Group type: EXPERIMENTAL
Intervention: Mass drug administration and standard of care package
Number of subjects: 1620
Study: 35325239

Group type: EXPERIMENTAL
Intervention: Flora imagery
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Sweepstakes
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Eco-friendly language
Number of subjects: 2000

Group type: EXPERIMENTAL
Intervention: Sweepstakes interaction
Number of subjects: 2000
Study: 32350413

Group type: EXPERIMENTAL
Intervention: Sequential nab-paclitaxel plus gemcitabine (SEQ)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Concomitant nab-paclitaxel plus gemcitabine (CON)
Number of subjects: 146
Study: 35861827

Group type: EXPERIMENTAL
Intervention: Avocado Supplemented
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Habitual Diet
Number of subjects: 1008
Study: 34506822

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 24
Study: 34894449

Group type: EXPERIMENTAL
Intervention: Nasal theophylline saline irrigation (twice a day for 6 weeks)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo saline irrigation (twice a day for 6 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nasal theophylline saline irrigation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo saline irrigation
Number of subjects: 22
Study: 34406329

Group type: EXPERIMENTAL
Intervention: Office-based vergence accommodative therapy (OBVAT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Office-based placebo therapy (OBPT)
Number of subjects: 100
Study: 32925744

Group type: EXPERIMENTAL
Intervention: MDL‐SHPVP (multidisciplinary team-led school-based HPV vaccination health-promotion program)
Number of subjects: 2520
Study: 34824710

Group type: EXPERIMENTAL
Intervention: Adductor Canal Block (ACB) alone (30 ml of 0.2% ropivacaine)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Periarticular Local Infiltration (PLI) alone (30 ml 0.5% ropivacaine in 20 ml of normal saline)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined ACB and PLI
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (ACB alone or PLI alone)
Number of subjects: 150
Study: 32003492

Group type: EXPERIMENTAL
Intervention: Stratified trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unstratified trials
Number of subjects: 0
Study: 34021607

Group type: EXPERIMENTAL
Intervention: 4 mg biperiden
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 32611602

Group type: EXPERIMENTAL
Intervention: Pulse oximeter sensor with opaque wrap
Number of subjects: 96

Group type: COMPARATOR
Intervention: Pulse oximeter sensor without opaque wrap
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Masimo sensor
Number of subjects: 96

Group type: COMPARATOR
Intervention: Nellcor sensor
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Babies receiving phototherapy
Number of subjects: 96
Study: 32777617

Group type: EXPERIMENTAL
Intervention: brief cognitive‐behavioral therapy (CBT) for suicide prevention
Number of subjects: 152

Group type: COMPARATOR
Intervention: treatment as usual
Number of subjects: 152
Study: 35977548

Group type: EXPERIMENTAL
Intervention: Abaloparatide 80 µg daily subcutaneous for 78 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33873217

Group type: EXPERIMENTAL
Intervention: Medical rehabilitation
Number of subjects: 211

Group type: COMPARATOR
Intervention: Continued routine care
Number of subjects: 211
Study: 35272517

Group type: EXPERIMENTAL
Intervention: Original recordings
Number of subjects: 186

Group type: COMPARATOR
Intervention: Low-pass filtered versions
Number of subjects: 186
Study: 34227081

Group type: EXPERIMENTAL
Intervention: Umbilical Cord Mesenchymal Stem Cells (UC‐MSC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 32058667

Group type: EXPERIMENTAL
Intervention: Use of the fourth arm of the da Vinci Si system during RAPN
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-use of the fourth arm of the da Vinci Si system during RAPN
Number of subjects: 58
Study: 36478476

Group type: EXPERIMENTAL
Intervention: Orismilast IR 30 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orismilast MR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33908683

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 316
Study: 32863057

Group type: EXPERIMENTAL
Intervention: Global Pelvic Manipulation (GPM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham ultrasound therapy
Number of subjects: 26
Study: 34958306

Group type: EXPERIMENTAL
Intervention: Precision SMS text messages (stage-targeted educational information, next dose due date, site-specific walk-in hours)
Number of subjects: 956

Group type: COMPARATOR
Intervention: Conventional SMS text messages (without educational information)
Number of subjects: 956

Group type: EXPERIMENTAL
Intervention: Any SMS text messages (precision or conventional)
Number of subjects: 956
Study: 36193880

Group type: EXPERIMENTAL
Intervention: Semaglutide (SEMA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dulaglutide (DULA)
Number of subjects: 0
Study: 32545396

Group type: EXPERIMENTAL
Intervention: Ambrotose Advanced (AA) at 2 or 4 g daily
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ambrotose LIFE (AL) at 2 or 4 g daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 34757148

Group type: EXPERIMENTAL
Intervention: Cuticular sutures placed 2 mm from the wound edge
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cuticular sutures placed 5 mm from the wound edge
Number of subjects: 50
Study: 34075142

Group type: EXPERIMENTAL
Intervention: Insulin glargine (IG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Neutral protamine Hagedorn (NPH)
Number of subjects: 50
Study: 34075644

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine-naloxone
Number of subjects: 111
Study: 32115328

Group type: EXPERIMENTAL
Intervention: Anesthesiologist administered ACB (group 1)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Surgeon administered ACB (group 2)
Number of subjects: 63
Study: 616357606

Group type: EXPERIMENTAL
Intervention: Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDCUSR) - 10 (n=5), 50 (n=2), 100 (n=4), or 200 x 10^6 (n=10) AMDCUSR in open-label studies; 150 x 10^6 AMDC-USR in RCT (n=11)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (n=6) in RCT
Number of subjects: 38
Study: 33801090

Group type: EXPERIMENTAL
Intervention: Silymarin-enriched maize grain extract (MEg-Sm, 0.24 g Sm L‒1 of MEg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maize grain extract (MEg, 2%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Silymarin (Sm, 0.5 mM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 34982493

Group type: EXPERIMENTAL
Intervention: 20 mg/day oral isotretinoin
Number of subjects: 26

Group type: COMPARATOR
Intervention: Isotretinoin 0.05% gel every night
Number of subjects: 26
Study: 32452161

Group type: EXPERIMENTAL
Intervention: Bibliotherapy (self-help materials) over 16 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 121
Study: 33120808

Group type: EXPERIMENTAL
Intervention: Ramelteon (Rozerem) administered 7 days prior and 7 days post-surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study: 35178367

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS) based on independent risk factors (age, surgery, stage, primary site, tumor size, histological type)
Number of subjects: 2059

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting CSS
Number of subjects: 2059
Study: 33148764

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TXA) - 1 g loading infusion followed by 125 mg/hour maintenance infusion until the end of surgery or 8 hours from incision
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo (saline indistinguishable from TXA)
Number of subjects: 115
Study: 36610532

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin (target INR, 2.0-2.5)
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard-dose warfarin (target INR, 2.5-3.5)
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin
Number of subjects: 401

Group type: COMPARATOR
Intervention: Standard-dose warfarin
Number of subjects: 401
Study: 34108430

Group type: EXPERIMENTAL
Intervention: Phenelzine
Number of subjects: 9
Study: 36449420

Group type: EXPERIMENTAL
Intervention: Deferiprone (15 mg/kg twice daily)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 372
Study: 34039476

Group type: EXPERIMENTAL
Intervention: Alloderm® (Regen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no Alloderm)
Number of subjects: 60
Study: 35144034

Group type: EXPERIMENTAL
Intervention: Endometrial scratching (ES) before embryo transfer
Number of subjects: 352

Group type: COMPARATOR
Intervention: No endometrial scratching (ES) before embryo transfer
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: At least one endometrial scratching (ES) before any embryo transfer
Number of subjects: 352

Group type: COMPARATOR
Intervention: No endometrial scratching (ES) before any embryo transfer
Number of subjects: 352
Study: 33578001

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS) administered ≤4 weeks postoperatively
Number of subjects: 133

Group type: COMPARATOR
Intervention: Stereotactic radiosurgery (SRS) administered >4 weeks postoperatively
Number of subjects: 133

Group type: COMPARATOR
Intervention: Delayed SRS
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 133
Study: 34893535

Group type: EXPERIMENTAL
Intervention: 3-year lifestyle intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 160
Study: 32824040

Group type: EXPERIMENTAL
Intervention: Interactive LBP intervention module based on the Back School Program
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 284
Study: 34887234

Group type: EXPERIMENTAL
Intervention: Intentionally treated water
Number of subjects: 2
Study: 35305796

Group type: EXPERIMENTAL
Intervention: Proportion of classmates receiving private tutoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher proportion of classmates receiving private tutoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Test-related stress as a mechanism
Number of subjects: 0
Study: 32152170

Group type: EXPERIMENTAL
Intervention: CBD 20 mg/kg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34157385

Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 0
Study: 32272334

Group type: EXPERIMENTAL
Intervention: Perceived cognitive impairment
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Disability measures
Number of subjects: 123
Study: 35279770

Group type: EXPERIMENTAL
Intervention: Treatment Program for Children with Aggressive Behavior (THAV)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 76
Study: 33663558

Group type: EXPERIMENTAL
Intervention: WeChat-based educational intervention (12-week duration, consisting of four individual online educational sessions and online educational materials)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: WeChat-based educational intervention
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 118
Study: 33487103

Group type: EXPERIMENTAL
Intervention: Arthrofibrosis group
Number of subjects: 539
Study: 34376241

Group type: EXPERIMENTAL
Intervention: Inulin supplementation
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 170
Study: 34224690

Group type: EXPERIMENTAL
Intervention: NIV with S-EPAP
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: NIV with T-EPAP
Number of subjects: 19

Group type: COMPARATOR
Intervention: No NIV
Number of subjects: 19
Study: 32324024

Group type: EXPERIMENTAL
Intervention: Guided-sampling phase with perceived actual contingency (Experiment 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided-sampling phase with inferred pseudocontingency (Experiment 2a and b)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free-sampling phase in reward-rich environments
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Free-sampling phase in reward-impoverished environments
Number of subjects: 0
Study: 35738650

Group type: EXPERIMENTAL
Intervention: rfMDA
Number of subjects: 8948

Group type: COMPARATOR
Intervention: RAVC
Number of subjects: 8948

Group type: EXPERIMENTAL
Intervention: rfMDA+RAVC
Number of subjects: 8948

Group type: COMPARATOR
Intervention: RACD
Number of subjects: 8948
Study: 32524612

Group type: EXPERIMENTAL
Intervention: Labeled glass (340-ml glasses of beer or wine)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Plain glass (control, 340-ml glasses of beer or wine)
Number of subjects: 162
Study: 34921902

Group type: EXPERIMENTAL
Intervention: Troponin I and T levels extracted from electronic health records (EHR)
Number of subjects: 0
Study: 35057782

Group type: EXPERIMENTAL
Intervention: Conventional + VR-assisted teaching (additional VR session took approximately 25-45 minutes)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional classes (about 15 minutes)
Number of subjects: 44
Study: 33625666

Group type: EXPERIMENTAL
Intervention: Yoga therapy for 3 months in addition to pharmacological treatment
Number of subjects: 140

Group type: COMPARATOR
Intervention: Pharmacological treatment only (Control)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Yoga therapy
Number of subjects: 140
Study: 32281269

Group type: EXPERIMENTAL
Intervention: Physical therapy‐led pathway
Number of subjects: 150

Group type: COMPARATOR
Intervention: Physician‐led pathway
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Healthcare utilization
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Safety and harm assessment
Number of subjects: 150